
New analysis shows the substitution would cut costs by $600 million in the United States annually.
New analysis shows the substitution would cut costs by $600 million in the United States annually.
The uncommon disease shares features of both lymphoma and myeloma.
The results of a pilot program investigating the efficacy of remote patient monitoring for patients with cancer showed that it helped to keep high-risk individuals out of the hospital.
Agency green light could help get medication off ASHP drug shortage list by reducing supply issues.
Immune B cells secrete immunoglobin A antibodies that work on mucosal surfaces in the nose, stomach, and lungs.
Inhibiting the activity of group 3 innate lymphoid cells could serve as a new therapeutic approach for neurologic conditions.
Study predicts the future of antibody testing may move toward technologically advanced platforms that can test for multiple antibody types in a single blood sample.
Commonly used medications may influence responses to checkpoint inhibitors among patients with cancer.
The FDA looks to address a lack of diversity in cancer drug trials.
Study indicates those who experienced a greater amount of stress from the COVID-19 pandemic had reduced information processing speed.
Chronic hypersensitivity pneumonitis is a long-term lung condition in which the interstitial tissue surrounding the alveoli of the lungs becomes inflamed and develops fibrosis.
Study suggests that emergency physicians prescribe naloxone to patients who overdose.
Common triggers for atrial fibrillation include alcohol, caffeine, and less sleep.
Immunocompromised individuals are at a higher risk of developing severe symptoms and dying from COVID-19.
Although marginal zone lymphoma is relatively rare, it contains a broad spectrum of conditions under it that require an individualized treatment selection process.
Study may help guide COVID-19 vaccination strategies for patients with blood disorders.
Researchers to explore possible approaches for designing small molecule therapeutics to combat depression.
Study shows moderately reduced efficacy of the Moderna COVID-19 vaccine over time against Delta infection, which supports current booster dose recommendations.
Major metabolites for cannabinoids may interfere with two families of enzymes that help metabolize a wide range of drugs prescribed for a variety of conditions.
Trial seeks to provide high-level evidence for improving the initial treatment for acute Kawasaki disease.
A single booster dose of the GlaxoSmithKline and Sanofi recombinant adjuvanted COVID-19 vaccine candidate delivered consistent and strong immune responses.
Up to 60% of arteriovenous fistulas fail to develop properly due to smooth muscle cell hyperplasia.
Patients with hormone receptor-positive breast cancer doubled their median progression-free survival following a switch to fulvestrant plus palbociclib.
Patients with breast cancer treated with pyrotinib plus capecitabine had a 31% lower risk of death than those treated with lapatinib and capecitabine
New technology provides information on the benefit of adding atezolizumab to chemotherapy as a neoadjuvant treatment for patients with early high-risk and locally advanced triple-negative breast cancer.
Experts reviewed the efficacy and safety of the recommended treatment regimens and discussed which treatment strategy they would recommend for their patients.
However, active disease alone for hospitalized patients was not associated with greater odds of dying from COVID-19, nor was receiving ongoing cancer treatment.
Uterine cancers that developed in patients with breast cancer treated with tamoxifen had fewer phosphoinositol-3-kinase (PI3K) pathway mutations and may have been driven by tamoxifen-induced PI3K pathway activation.
Emicizumab-kxwh demonstrated a favorable safety profile and effective bleed control in people with mild or moderate hemophilia A without factor VIII inhibitors.
The study demonstrates a need for novel tolerable and efficacious therapeutic agents to address the burden of illness in patients with multiple myeloma, according to the investigators.
Published: November 30th 2021 | Updated:
Published: March 23rd 2021 | Updated:
Published: April 13th 2021 | Updated:
Published: October 21st 2021 | Updated:
Published: April 16th 2021 | Updated:
Published: April 12th 2021 | Updated: